Skip to navigation menu Skip to content
Jump to:  A   |   B   |   C   |   D   |   E   |   F   |   G   |   H   |   I   |   J   |   K   |   L   |   M   |   N   |   O   |   P   |   Q   |   R   |   S   |   T   |   U   |   V   |   W   |   X   |   Y

Moderna Says Its COVID Vaccine Works Well in Children Aged 6 to 11

Moderna Says Its COVID Vaccine Works Well in Children Aged 6 to 11

MONDAY, Oct. 25, 2021 (HealthDay News) -- Moderna announced Monday that its COVID-19 vaccine safely triggers a strong immune response in children aged 6 to 11.

Company data shows that a month after receiving both doses of the vaccine, children's antibody levels were 1.5 times higher than those in young adults. The company did not release the full data on the shots and the results have not been published in a peer-reviewed journal.

"We are encouraged by the immunogenicity and safety profile of mRNA-1273 [Moderna's vaccine] in children aged 6 to under 12 years and are pleased that the study met its primary immunogenicity endpoints," said Stéphane Bancel, chief executive officer of Moderna. "We look forward to filing with regulators globally and remain committed to doing our part to help end the COVID-19 pandemic with a vaccine for adults and children of all ages."

The trial included more than 4,700 children who received two shots of the vaccine 28 days apart. Each shot contained 50 micrograms of vaccine, half the adult dose. Most side effects were mild or moderate, and the most common were fatigue, headache, fever and pain at the injection site, according to Moderna.

The vaccine's safety will continue to be reviewed by an independent monitoring committee for 12 months after the second dose, The New York Times reported.

Moderna is still recruiting children aged 2 through 5, and 6 months to under 2 years for trials of the vaccine in those age groups. So far, the company has enrolled about 5,700 children in the United States and Canada in that trial.

On Tuesday, a U.S. Food and Drug Administration advisory committee is scheduled to weigh the use of the Pfizer coronavirus vaccine in children aged 5 through 11.

In June, Moderna submitted trial results for use of its COVID-19 vaccine in youth aged 12 through 17, but the FDA has not yet announced a decision for that age group, the Times reported.

Some research indicates that the Moderna vaccine may increase the risk of a rare side effect of heart muscle inflammation (myocarditis) in boys and young men. In July, the FDA asked both Pfizer and Moderna to increase the size of their trials to try to detect less common side effects, the Times reported.

More information

Visit the U.S. Food and Drug Administration for more on COVID vaccines.

SOURCES: Moderna, news release, Oct. 25, 2021; The New York Times

Reviewed Date: --

Find a pediatrician
Childrens Orthopedics and Sports Medicine
Dr. James Bennett
Dr. J. Marc Cardelia
Dr. Peter Moskal
Dr. Cara Novick
Dr. Carl St. Remy
Sports Medicine
Dr. Joel Brenner
Dr. Aisha Joyce
Dr. Micah Lamb
Dr. David Smith
Infectious Diseases
Dr. Randall Fisher
Dr. Jean Kim
Dr. Laura Sass
Health Tips
Helping Kids Get Over their Fears
When Can a Child Wear Contact Lenses
Immunization Quiz
Teen Health Quiz
Diseases & Conditions
Adolescent (13 to 18 Years)
Amenorrhea in Teens
Anatomy of a Child's Brain
Anatomy of the Endocrine System in Children
Anxiety Disorders in Children
Asthma in Children Index
Becker Muscular Dystrophy (BMD) in Children
Bone Marrow Transplant for Children
Brain Tumors in Children
Breast Conditions in Young Women
Chemotherapy for Children: Side Effects
Ewing Sarcoma in Children
Female Growth and Development
Gynecological and Menstrual Conditions
Hepatitis B Virus (HBV) in Children
High Blood Pressure in Children and Teens
Home Page - Adolescent Medicine
Inflammatory and Infectious Musculoskeletal Disorders
Inflammatory and Infectious Neurological Disorders
Inguinal Hernia in Children
Insect Bites and Children
Kidney Transplantation in Children
Major Depression in Teens
Meningitis in Children
Menstrual Cramps (Dysmenorrhea) in Teens
Menstrual Disorders
Mood Disorders in Children and Adolescents
Myasthenia Gravis (MG) in Children
Oral Health
Osteosarcoma (Osteogenic Sarcoma) in Children
Pap Test for Adolescents
Pediatric Blood Disorders
Posttraumatic Stress Disorder (PTSD) in Children
Preparing the School-Aged Child for Surgery
Schizophrenia in Children
School-Aged Child Nutrition
Sports Safety for Children
Superficial Injuries of the Face and Head- Overview
Teens and Diabetes Mellitus
Television and Children
The Growing Child- Teenager (13 to 18 Years)
The Growing Child: 2-Year-Olds
The Heart
The Kidneys
Your Child's Asthma
Your Child's Asthma: Flare-ups

Disclaimer: This information is not intended to substitute or replace the professional medical advice you receive from your child's physician. The content provided on this page is for informational purposes only, and was not designed to diagnose or treat a health problem or disease. Please consult your child's physician with any questions or concerns you may have regarding a medical condition.